Patent Assignment
Reel/Frame 029062/0639
Release of Security Interest
Recorded: 2012-10-02
Pages: 9
Assignor
ELI LILLY AND COMPANY
Executed: 2012-08-08
Assignee
AMYLIN PHARMACEUTICALS, INC.
9360 TOWNE CENTER DRIVE, SAN DIEGO, CALIFORNIA, 92121
Covered Properties
(3)
Gip Analog and Hybrid Polypeptides with Selectable Properties
Methods to Restore Glycemic Control
Use of Exendins and Exendin Agonists and Glp-1 Receptor Agonists for Altering the Concentration of Fibrinogen
Related Assignments
(4)
Other recorded transfers of the patents in this record — the chain of ownership.
Security Agreement
Nov 8, 2011
From: AMYLIN PHARMACEUTICALS, INC.
To: ELI LILLY AND COMPANY
Reel/Frame 027192/0334 →
Corrective Assignment to Correct the Absence of the Second Assignee Listed on Joint Assignment Previously Recorded on Reel 022985 Frame 0371. Assignor(S) Hereby Confirms the Assignment of the Equal Undivided Right, Title and Interest.
Apr 11, 2012
From: KIM, DENNIS; TRAUTMANN, MICHAEL
To: AMYLIN PHARMACEUTICALS, INC.; ELI LILLY AND COMPANY
Reel/Frame 028030/0884 →
Change of Name
Oct 25, 2012
From: AMYLIN PHARMACEUTICALS, INC.
To: AMYLIN PHARMACEUTICALS, LLC
Reel/Frame 029198/0345 →
Amylin Pharmaceuticals, Llc Assigns an Equal and Undivided One-Half of Its Entire Right, Title and Interest to Astrazeneca Pharmaceuticals Lp
Oct 26, 2012
From: AMYLIN PHARMACEUTICALS, LLC
To: ASTRAZENECA PHARMACEUTICALS LP
Reel/Frame 029195/0555 →